Displaying 69 France Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Eligo Bioscience

Gene-editing platform.

64
$30M · Series B Khosla Ventures, Sanofi Ventures, Bpifrance 11 to 50 Health Tech, Biotech Paris, France •••••••••••@eligo.bio
Aqemia

Drug discovery platform.

64
$32M · Series A Wendel Growth, Bpifrance, Elaia 51 to 100 Biotech B2B Paris, France •••••••••••@aqemia.com
HEPHAISTOS-Pharma HIRING

Immunotherapies developer for cancer patient.

64
$4M · Seed Fournier-Majoie, France 2030, Elaia 1 to 10 Health Tech, Biotech Paris, France •••••••••••@hephaistos-pharma.fr
Bioptimus

Developer of a universal AI foundation model for biology.

64
$35M · Seed Frst, Bpifrance, Sofinnova Partners 1 to 10 AI, Biotech B2B, SaaS Paris, France •••••••••••@bioptimus.com
Cure51

Cancer survivors data analysis platform.

64
$16M · Seed Hitachi Ventures, Life Extension Ventures, Sofinnova Partners 11 to 50 Biotech, Data and Analytics B2B, SaaS Paris, France •••••••••••@cure51.com
Mnemo Therapeutics

Biotechnology firm focused on life science advancements.

59
$89M · Series A Sofinnova Partners 101 to 250 Health Tech, Biotech B2B Paris, France •••••••••••@mnemo-tx.com
En Carta DiagnosticsJUST ADDED HIRING

Point-of-care diagnostic platform.

59
$1M · Pre Seed CentraleSupélec Venture 1 to 10 Health Tech, Biotech Paris, France •••••••••••@encarta.bio
Adionics

Eco-friendly liquid-liquid direct lithium extraction (DLE) process developer.

59
$27M · Series B Bpifrance, Celeste Management, Sociedad Quimica Y Minera (SQM) 11 to 50 Climate Tech & Green Tech, Biotech B2B Paris, France •••••••••••@adionics.com
SparingVision

Biotechnology company focused on developing genomic medicines to treat blinding inherited retinal diseases.

59
$52M · Series A Ysios Capital 1 to 10 Health Tech, Biotech, Deep Tech B2B Paris, France •••••••••••@sparingvision.com
MetyosJUST ADDED

Biosensors developer to combat chronic kidney disease.

59
$2M · Pre Seed Bpifrance, Kima Ventures, Cenitz 1 to 10 Health Tech, Biotech Paris, France •••••••••••@metyos.com
Eyevensys

Platform that develops bio factories to treat significant eye diseases sustainably.

54
$30M · Series B Karista, Pureos Bioventures 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Paris, France •••••••••••@eyevensys.com
Gradient Denervation Technologies

Medical devices for a transvascular treatment of pulmonary hypertension.

54
$14M · Series A Sofinnova Partners, Asabys Partners 1 to 10 Health Tech, Biotech Paris, France •••••••••••@gradientdenervation.com
Samabriva

Biomanufacturer of complex molecules.

54
$4M · Seed Meusinvest (Noshaq) 1 to 10 Biotech, Manufacturing Paris, France •••••••••••@samabriva.com
Astraveus

Automated bioprocessing system for the production of cell and gene therapies.

54
$18M · Seed AdBio Partners 11 to 50 Biotech Paris, France •••••••••••@astraveus.com
Egle Therapeutics

Biotechnology firm developing immunotherapies for cancer and autoimmune diseases.

54
$46M Bioqube Ventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@egle-tx.com
nextProtein

Technology transforming large-scale protein production for sustainability.

50
$11M · Series A Blue Oceans Partners 11 to 50 Climate Tech & Green Tech, Agritech, Foodtech, Biotech, Manufacturing B2B Paris, France •••••••••••@nextprotein.co
Biomemory

Solution for storing large amounts of computer data on long DNA strands at a low cost.

50
$5M Bpifrance 1 to 10 Health Tech, Biotech, Data and Analytics, Business Intelligence Paris, France •••••••••••@biomemory-labs.com
May HealthJUST ADDED HIRING

PCOS infertility treatment developer.

50
$10M · Series A Bpifrance, Avestria Ventures, Trill Impact 1 to 10 Health Tech, Biotech Paris, France •••••••••••@mayhealth.com
LinKinVax

Protein-based vaccines.

50
$7M · Series A In-Q-Tel 1 to 10 Biotech Paris, France •••••••••••@linkinvax.com
PathoQuest

Biotech solution providing NGS-based metagenomic tests to fully identify pathogens.

50
$8M Eurazeo, Norgine Ventures, Verve Ventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@pathoquest.com
PiLi

Petroleum-free pigments.

50
$15M · Series A Bpifrance, Elaia 11 to 50 Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing B2B Paris, France •••••••••••@pili.bio
Kiro

AI-dirven clinical biology.

50
$14M · Series A Sofinnova Partners 11 to 50 Biotech Paris, France •••••••••••@kiro.bio
Enterome

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

50
$3M · Series F The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Paris, France •••••••••••@enterome.com
Corteria Pharmaceuticals

Interceptive therapies for heart failure subpopulations.

50
$12M · Seed OrbiMed, Invivo Capital Partners, Omnes Capital 1 to 10 Health Tech, Biotech Paris, France •••••••••••@corteriapharma.com
Nūmi

Breast milk producer from cell-cultured mammary glands.

50
$3M · Pre Seed Heartcore, Kima Ventures, Kost Capital 1 to 10 Biotech, FamilyTech & Parenting B2C Paris, France •••••••••••@numi.life
EverImmune

Developer of biotherapeutic products to treat cancer.

50
$3M · Debt Financing Bpifrance 1 to 10 Health Tech, Biotech Paris, France •••••••••••@everimmune.net
Ermium Therapeutics

Biotech firm developing treatments for auto-immune diseases.

50
$6M · Series A Fountain Healthcare Partners 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@ermium.com
Stilla Technologies

Biotechnology company based in Paris, focusing on innovative genetic analysis solutions.

50
$12M Eurazeo 11 to 50 Health Tech, Biotech, Genetics B2B Paris, France •••••••••••@stillatechnologies.com
Qubit Pharmaceuticals

Platform that accelerates drug discovery using advanced computational techniques.

50
$17M · Seed Quantonation, XAnge 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Paris, France •••••••••••@qubit-pharmaceuticals.com
Tissium

Niodegradable sealants and adhesives for wound closure.

50
$8M · Series A Bpifrance, CM-CIC Capital Finance, Sofinnova Partners 51 to 100 Health Tech, Hardware, Biotech, Manufacturing B2B Paris, France •••••••••••@tissium.com
BrightHeart

AI to detect congenital heart defects in fetuses.

43
$2M · Seed Sofinnova Partners 1 to 10 AI, Biotech Paris, France •••••••••••@brightheart.fr
SurgeJUST ADDED

AI-driven high-dimensional immune system analysis platform.

43
$2M · Pre Seed Kima Ventures, Eurazeo, Boutique Venture Partners 1 to 10 AI, Biotech B2B, SaaS Paris, France •••••••••••@surge.care
Core Biogenesis

Biotechnology platform developing advanced recombinant protein production technologies.

43
$3M · Seed Entrepreneur First, Thia Ventures, XAnge 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Paris, France •••••••••••@corebiogenesis.com
Amatera

Non-GMO breeding platform.

43
$1M · Pre Seed PINC, Exceptional Ventures, Joyance Partners 1 to 10 Agritech, Biotech B2B Paris, France •••••••••••@amatera.bio
FairCraft

Platform creating lab-grown alternatives to animal leather using synthetic biology and material science.

43
$3M · Seed Kindred Capital, Entrepreneur First 1 to 10 Climate Tech & Green Tech, Fashion, Biotech, Manufacturing B2B Paris, France •••••••••••@faircraft.bio
Honing Biosciences

Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases

43
$2M · Pre Seed Elaia 1 to 10 Health Tech, Biotech B2B Paris, France •••••••••••@honing-biosciences.com
Step Pharma

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

43
$2M · Seed Bpifrance, Idinvest Partners, AGORANOV 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@step-ph.com
Seafood Reboot

PLANT-BASED MARINE SUBSTITUTES WITH ALGAE INGREDIENTS. FOR NATURAL, HEALTHY, SUSTAINABLE FOOD

43
$3M · Pre Seed Founders Future, Demeter Partners 1 to 10 Agritech, Foodtech, Biotech, Manufacturing B2B, B2C Paris, France •••••••••••@seafood-reboot.com
ENYO Pharma

Vonafexor drug maker for the treatment of Alport syndrome.

42
$42M · Series C Bpifrance, Sofinnova Partners, OrbiMed 1 to 10 Biotech Lyon, France •••••••••••@enyopharma.com
HawkCell

MRI plug-and-play solution developer for veterinary use.

42
$5M · Series A Bpifrance, MIG Capital 11 to 50 Health Tech, Biotech Lyon, France •••••••••••@hawkcell.com
Antabio

Developer of MEM-ANT3310, a next generation antibacterial combination.

42
$26M · Series B BNP Paribas, EIC Accelerator, AMR Action Fund 11 to 50 Health Tech, Biotech Toulouse, France •••••••••••@antabio.com
WhiteLab Genomics

Platform for gene and cell therapy companies to develop cheaper drugs faster using digital tools.

39
$500k · Pre Seed Y Combinator 11 to 50 Health Tech, Biotech, Genetics, Business Intelligence B2B, SaaS Paris, France •••••••••••@whitelabgx.com
Coave Therapeutics

Gene therapies for rare diseases.

39
$490k · Seed Bpifrance, Idinvest Partners, Omnes Capital 11 to 50 Health Tech, Biotech, Deep Tech B2B Paris, France •••••••••••@coavetx.com
InSpek

Monitoring system for biological and chemical analysis using integrated photonics.

39
$573k · Pre Seed Quantonation 1 to 10 Biotech, Data and Analytics, Robotics, Navigation and Mapping, Manufacturing, Business Intelligence B2B Paris, France •••••••••••@inspek-solutions.com
Inato

AI-powered data collecting tool for clinical trials.

39
$1M · Seed Kima Ventures, Cathay Innovation, Serena 11 to 50 Health Tech, AI, Biotech, Machine Learning, Pharma B2B, SaaS Paris, France •••••••••••@inato.com
Sensorion

Therapeutic treatment for hearing loss disorders.

37
$38M · Series B Sofinnova Partners, Invus 11 to 50 Health Tech, Biotech B2C Montpellier, France •••••••••••@sensorion.com
Alira Health

International advisory firm for healthcare sector.

37
$58M · Series C 101 to 250 Health Tech, Biotech Paris, France •••••••••••@alirahealth.com
Diabeloop

Medical device company that develops systems to help manage diabetes automatically.

37
$73M Supernova Invest, Innovacom 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Grenoble, France •••••••••••@diabeloop.fr
Amolyt Pharma

Peptides for the treatment of rare endocrine and related diseases.

37
$138M · Series C Sofinnova Partners, Intermediate Capital Group 11 to 50 Biotech Lyon, France •••••••••••@amolytpharma.com
RebrAIn

Commercial-stage precision neuro-surgery platform.

37
$4M · Seed NACO, Karista 1 to 10 Health Tech, Biotech Bordeaux, France •••••••••••@rebrain.eu
ImCheck Therapeutics

Platform developing new treatments that focus on the butyrophilin family's checkpoint molecules.

37
$102M Earlybird Venture Capital, Eurazeo, Andera Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Marseille, France •••••••••••@imchecktherapeutics.com
AbolerIS Pharma

Therapeutic platform focused on developing treatments that promote immune tolerance.

37
$29M · Series A Caixa Capital Risc, Sound Bioventures 1 to 10 Health Tech, Biotech, Pharma B2B Nantes, France •••••••••••@aboleris-pharma.com
InnovaFeed

Biotech firm producing insect-based protein for animal feed.

37
$250M · Series D 101 to 250 Biotech, Deep Tech Paris, France •••••••••••@innovafeed.com
Netris Pharma

Developer of therapeutic molecules to treat cancer.

37
$8M · Series A EIC Accelerator 1 to 10 Health Tech, Biotech Lyon, France •••••••••••@netrispharma.com
AlgoTherapeutix

Topical treatments for complex pain.

34
$21M · Series B 1 to 10 Health Tech, Biotech Paris, France •••••••••••@algotx.com
Corlieve Therapeutics

Biotechnology company focused on developing gene therapies for neurological disorders.

34
N/A Pureos Bioventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@corlieve.com
DeepLife

Platform that uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.

34
N/A Kima Ventures, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Machine Learning B2B Paris, France •••••••••••@trydeeplife.org
Depixus

Genetic analysis technology for decoding the dynamic genome.

34
$35M · Series A 11 to 50 Health Tech, Biotech, Manufacturing, Genetics B2B Paris, France •••••••••••@depixus.com
EG 427

Developing pinpoint gene therapy.

34
$5M · Series A 11 to 50 Health Tech, Biotech B2C Paris, France •••••••••••@eg427.com
Neoplants

Houseplants developer to remove harmful air pollutants.

34
N/A Heartcore, Entrepreneur First, True Ventures 11 to 50 Agritech, Biotech B2C Paris, France •••••••••••@neoplants.co
Red Horticulture

Platform for horticulture LED lighting systems, photobiology research, and indoor and greenhouse lighting.

31
$18M · Series A European Circular Bioeconomy Fund (ECBF), Demeter Partners, Unigrains 11 to 50 Climate Tech & Green Tech, Agritech, Biotech, Energy & Nuclear, Manufacturing B2B Lyon, France •••••••••••@horticulture.red
EverImmune

Therapeutic tools for treating cancer.

31
$5M · Series A 1 to 10 Health Tech, Biotech, Manufacturing B2B Paris, France •••••••••••@everimmune.com
Bon Vivant

Animal-free dairy protein.

31
$15M · Series A Kima Ventures, Founders Future, Sofinnova Partners 11 to 50 Biotech B2C Lyon, France •••••••••••@bonvivant-food.com
Damae Medical

Imaging technology for quick and non-invasive skin cancer detection.

31
$5M · Series A 11 to 50 Health Tech, Hardware, Biotech, Business Intelligence B2B, SaaS Paris, France •••••••••••@damae-medical.com
BforCure

Biotech firm specializing in the production of rapid biosensing devices like the CHRONOS PCR.

28
$2M · Seed 11 to 50 Health Tech, Biotech, Manufacturing B2B Paris, France •••••••••••@bforcure.com
Qynapse

Platform combining MRI scans and AI to produce rapid, actionable insights into central nervous system disorders.

28
$2M · Seed 11 to 50 Health Tech, AI, Biotech, Deep Tech, Machine Learning, Data and Analytics B2B, SaaS Paris, France •••••••••••@qynapse.com
Microphyt

Natural algae-based products supporting weight loss and brain health research, development, and production.

26
$15M Bpifrance, Sofinnova Partners, Supernova Invest 11 to 50 Health Tech, Agritech, Foodtech, Biotech, Fitness, Energy & Nuclear Montpellier, France •••••••••••@microphyt.eu
Cell-Easy

CDMO specializing in preclinical and clinical drug development.

26
$8M M Capital Partners 11 to 50 Health Tech, Biotech, Manufacturing B2B Toulouse, France •••••••••••@cell-easy.com
4P-PharmaJUST ADDED HIRING

Developer of innovative curative therapies.

26
$16M · Series A 11 to 50 Health Tech, Biotech Lille, France •••••••••••@4p-pharma.com